Intercept Pharmaceuticals, Inc.
ICPT · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,760 | -$5,826 | -$31,881 | -$17,000 |
| Dep. & Amort. | $97 | $90 | $89 | $101 |
| Deferred Tax | $1,152 | -$2,428 | $0 | $0 |
| Stock-Based Comp. | $6,653 | $6,262 | $5,864 | $5,231 |
| Change in WC | $10,960 | -$22,116 | -$24,080 | $9,930 |
| Other Non-Cash | $584 | $716 | -$1,589 | -$3,068 |
| Operating Cash Flow | $16,686 | -$23,302 | -$51,597 | -$4,806 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13 | -$98 | $0 | $297 |
| Net Acquisitions | -$59,787 | $0 | $0 | $55,232 |
| Inv. Purchases | -$34,894 | -$90,658 | -$55,629 | -$151,668 |
| Inv. Sales/Matur. | $94,681 | $187,628 | $121,181 | $96,436 |
| Other Inv. Act. | $59,787 | $74 | -$6,229 | -$55,232 |
| Investing Cash Flow | $59,774 | $96,946 | $59,323 | -$54,935 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$33 | -$49 | -$269 | -$77 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$109,999 | -$43 | -$254 | -$5,672 |
| Financing Cash Flow | -$109,999 | -$43 | -$254 | -$5,672 |
| Forex Effect | -$166 | $736 | -$308 | $1,097 |
| Net Chg. in Cash | -$33,705 | $74,337 | $7,164 | -$64,316 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $137,361 | $63,024 | $55,860 | $120,176 |
| End Cash | $103,656 | $137,361 | $63,024 | $55,860 |
| Free Cash Flow | $16,673 | -$23,400 | -$51,597 | -$4,509 |